Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells

被引:103
作者
Reynolds, Paul A.
Sigaroudinia, Mahvash
Zardo, Giuseppe
Wilson, Matthew B.
Benton, Geoffrey M.
Miller, Caroline J.
Hong, Chibo
Fridlyand, Jane
Costello, Joseph F.
Tlsty, Thea D.
机构
[1] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
关键词
D O I
10.1074/jbc.M604175200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alterations in DNA methylation are important in cancer, but the acquisition of these alterations is poorly understood. Using an unbiased global screen for CpG island methylation events, we have identified a non-random pattern of DNA hypermethylation acquired in p16-repressed cells. Interestingly, this pattern included loci located upstream of a number of homeobox genes. Upon removal of p16(INK4A) activity in primary human mammary epithelial cells, polycomb repressors, EZH2 and SUZ12, are upregulated and recruited to HOXA9, a locus expressed during normal breast development and epigenetically silenced in breast cancer. We demonstrate that at this targeted locus, the up-regulation of polycomb repressors is accompanied by the recruitment of DNA methyltransferases and the hypermethylation of DNA, an endpoint, which we show to be dependent on SUZ12 expression. These results demonstrate a causal role of p16INK4A disruption in modulating DNA hypermethylation, and identify a dynamic and active process whereby epigenetic modulation of gene expression is activated as an early event in breast tumor progression.
引用
收藏
页码:24790 / 24802
页数:13
相关论文
共 58 条
[1]   Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma [J].
Alaminos, M ;
Davalos, V ;
Cheung, NKV ;
Gerald, WL ;
Esteller, M .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (16) :1208-1219
[2]  
[Anonymous], 1993, Resampling-based multiple testing: Examples and methods for P-value adjustment
[3]   Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene [J].
Bachman, KE ;
Park, BH ;
Rhee, I ;
Rajagopalan, H ;
Herman, JG ;
Baylin, SB ;
Kinzler, KW ;
Vogelstein, B .
CANCER CELL, 2003, 3 (01) :89-95
[4]   Promoter hypermethylation - Can this change alone ever designate true tumor suppressor gene function? [J].
Baylin, SB ;
Herman, JG .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (09) :664-665
[5]  
Belinsky SA, 2002, CANCER RES, V62, P2370
[6]   Control of morphogenesis and differentiation by HOM/Hox genes [J].
Botas, Juan .
CURRENT OPINION IN CELL BIOLOGY, 1993, 5 (06) :1015-1022
[7]   EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer [J].
Adrian P. Bracken ;
Diego Pasini ;
Maria Capra ;
Elena Prosperini ;
Elena Colli ;
Kristian Helin .
The EMBO Journal, 2003, 22 (20) :5323-5335
[8]   Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation [J].
Brenner, AJ ;
Stampfer, MR ;
Aldaz, CM .
ONCOGENE, 1998, 17 (02) :199-205
[9]   Homeobox A9 transcriptionally regulates the EphB4 receptor to modulate endothelial cell migration and tube formation [J].
Bruhl, T ;
Urbich, C ;
Aicher, D ;
Acker-Palmer, A ;
Zeiher, AM ;
Dimmeler, S .
CIRCULATION RESEARCH, 2004, 94 (06) :743-751
[10]   Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer [J].
Cameron, EE ;
Bachman, KE ;
Myöhänen, S ;
Herman, JG ;
Baylin, SB .
NATURE GENETICS, 1999, 21 (01) :103-107